American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers - Wikidata - awgldk - TriplyDB

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

http://www.wikidata.org/entity/Q30416965

about

Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women.Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS).An internal performance assessment of CancerGene Connect: an electronic tool to streamline, measure and improve the genetic counseling process.The History and Physical in Cancer Care: A Primer for the Oncology Advanced Practitioner Contribution of extended family history in assessment of risk for breast and colon cancer.Protocol for the "Implementation, adoption, and utility of family history in diverse care settings" study.ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond Incorporating genetic counseling into clinical care for children and adolescents with cancer.Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics.Self-reported cancer family history is a useful tool for identification of individuals at risk of hereditary cancer predisposition syndrome at primary care centers in middle-income settings: a longitudinal study Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature.Contemporary Challenges in Genetic Testing for Breast Cancer: A Collaboration Opportunity for Genetic Counselors and Breast Surgeons.High-Definition Medicine.Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment.A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.A model for patient-direct screening and referral for familial cancer risk.Sarcomas Associated With Genetic Cancer Predisposition Syndromes: A Review.Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?Population Landscape of Familial Cancer.BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?The impact of hereditary cancer gene panels on clinical care and lessons learned.Family history-taking practices and genetic confidence in primary and tertiary care providers for childhood cancer survivors.Genetics educational needs in China: physicians' experience and knowledge of genetic testing.American Cancer Society prostate cancer survivorship care guidelines.Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer.Role of family history and tumor location on prognosis of patients with colorectal cancer and synchronous metastases.Clinically relevant lessons from Family HealthLink: a cancer and coronary heart disease familial risk assessment tool.Issues related to family history of cancer at the end of life: a palliative care providers' survey.Placing negative multi-gene panel results into clinical context.How I diagnose and manage individuals at risk for inherited myeloid malignancies.Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene What characterizes cancer family history collection tools? A critical literature review Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care

P2860

Q30620701-DA66F8A9-DAF4-448F-A8B6-7C421D95FE43 Q33647706-E8DC52FD-7669-402A-AAF5-789CC1A80ED2 Q33840804-8A75B651-9596-488B-9A6D-FDFB97E9F94B Q34518307-570B5685-3198-45F1-888C-81069C2F819C Q35687579-6391036D-CE65-43F7-BAE9-4DC5814C433D Q36118708-72999647-6AFE-4F4D-9AA6-D170433B736C Q36310806-C9895B59-0E3B-46A6-B75E-5DF6423DD13F Q36416282-422BAC66-2410-4BD8-BAB8-D05FDB9E2F38 Q36619933-BCE71FEC-2285-464A-AC19-193E4B6575CB Q36765209-012913D1-FDCD-45E0-9258-09C37EF8EF38 Q36849670-F1A80BAB-5446-4DD4-8CAF-3EC21F97F3CD Q36914464-D0643AC9-7142-4A09-A6A2-F2C9138DA858 Q37011941-896FF2C1-001A-43DE-B50A-2A13F37C8832 Q37661436-2DB296D8-9C21-4E8D-AE20-BB1E9E4E2A69 Q38555226-4182484A-4EE8-48CC-884E-BCA31440D838 Q38608277-D16C8760-3817-4632-BD73-18242A084ED1 Q38681805-944E31E0-1852-4BB1-BA42-CDC4FD24A4C1 Q38727225-D807244C-C030-4468-B45B-ECE53A948724 Q38879087-C7F18D7D-16E8-43DE-AF7B-489C431EAA9E Q38893082-EB8DA610-D9F8-4682-B27D-7A97E68CB346 Q38948810-9A692FDD-BC24-4C83-BD07-EA8E2F853D89 Q40643761-C2763925-A365-43A2-B461-96C5DC92CFE2 Q44813406-258D2FAD-47FB-4396-8D7F-0F09391C31F1 Q47157369-E35A8785-D7A6-4972-884E-582FF96FDD74 Q47234680-12D80BD5-3439-4259-B812-27C56A22C6E1 Q48056358-5435546E-7F7A-46D2-B506-1DFB589CFF4C Q48073617-3DDA277B-B9E5-4EA3-8FDF-070B797E28CC Q48151859-054D2AB5-3A46-4F5E-AFD5-F2FFBEFCBDC0 Q48160519-F2D490DE-5084-4F58-871B-147C8137FC32 Q48256947-13273A72-C755-43B5-9A08-ABF7820BA036 Q53833601-02BFFDB2-0E9E-4E56-87BE-4DF6D8C35AFA Q53902612-2658A10B-6654-4993-A85A-ED5E0F73A2C3 Q55155177-D10CE576-5583-456F-BFF6-655E0D433BE7 Q57146860-AC0B89F8-4135-46A5-8B1C-44BF7D3C4097 Q58783269-6A5DA178-8354-49A4-B82E-38314A7A6BA7 Q58786293-C97C99E1-174C-4182-B7FD-E5F97E233ACB

P2860

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

http://www.wikidata.org/entity/Q30416965

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

American Society of Clinical O ...... history for oncology providers

@ast

American Society of Clinical O ...... history for oncology providers

@en

type

label

American Society of Clinical O ...... history for oncology providers

@ast

American Society of Clinical O ...... history for oncology providers

@en

prefLabel

American Society of Clinical O ...... history for oncology providers

@ast

American Society of Clinical O ...... history for oncology providers

@en

P1433

Q30416965-315E43E8-BC49-4C69-ADCC-24643D381488

P1476

Q30416965-4705DAE4-6AAB-4813-AF99-368CEDC42D31

P2093

Q30416965-0193CAFA-0720-46F2-A2E5-058E31E990E7

Q30416965-0327566C-B662-4DE6-B359-470CDD7B7F04

Q30416965-18F9CFFB-54AF-41DC-9320-16B5CDE06897

Q30416965-3A4726E9-20C1-4FD6-8640-3A53508BCBEA

Q30416965-3CFDDA46-5D65-4F74-8DE9-C63FEA701DD4

Q30416965-3D0D635A-C6CF-4608-8668-9D56899FEA0B

Q30416965-5EDC7411-6BD2-4234-9289-B45DF3B00D3A

Q30416965-66006AEF-9292-4D1A-A28E-A55C225BED20

Q30416965-6FF5D582-1C92-4BC7-8066-62BA396033F8

Q30416965-92B4108C-5945-4204-98F5-2672EBC9D7FC

P2860

Q30416965-05FC0383-ED7D-4149-8F94-2CE74D32E0F3

Q30416965-0B6DA69E-764D-459F-B6AA-45B5FCB6897B

Q30416965-0D33E56C-97C8-4945-BDE2-49220C07C2F9

Q30416965-13982B4A-9134-432D-8674-F0D8B9497C5D

Q30416965-1FEB4BC1-D5F9-437E-8E0E-55DE268FC014

Q30416965-268D7D2A-A228-4752-9B8B-0CF9CEC6E9A7

Q30416965-26F2FD7A-11DC-4342-85F9-ECE1B744A3C9

Q30416965-291AD4EE-4F2C-4CC5-BD63-07F2CF67EF53

Q30416965-2CA0DE70-4DC2-4266-9FFE-AFA370A73303

Q30416965-3063AFC6-F3E6-4AE2-A2F7-1C9890C53F64

P304

Q30416965-E45043B2-BDA6-47B6-A3B7-FF44DAFB47B6

P31

Q30416965-9E40C781-2511-48A0-ADE4-AFBD3C7B80D0

P356

Q30416965-D027DD09-1A94-40F5-A242-DB3DC9D23153

P407

Q30416965-07318775-F8E6-4DF5-8425-C332766C80A6

P433

Q30416965-E7A6142D-180F-4508-95EE-F7F1B6DCE729

P478

Q30416965-02E76895-E1A6-4DC9-BE22-951E38A2CDC2

P50

Q30416965-0D297DEB-F1CE-4D22-BB9B-823D1696DFDA

Q30416965-7A3DC59C-A0FA-468A-B44D-C440A7FC3260

Q30416965-C130E0BB-28D8-4EF7-A023-CFFD246F9615

Q30416965-DDA094F3-9CBB-4779-8B98-B9FD39F6FEF2

Q30416965-FCB7D3C2-C87B-44B8-A91B-0AD0169A1E4F

P577

Q30416965-69CEA92A-6BEC-420B-AB3A-2E59C88C471C

P698

Q30416965-6A1F361B-F225-4B37-8260-8CB2EA9DF006

P932

Q30416965-CC54D704-8D45-4606-AE77-1C5E23C8E8AB

P356

JCO.2013.50.9257

P1433

Journal of Clinical Oncology

P1476

American Society of Clinical O ...... history for oncology providers

@en

P2093

Carrie Snyder

http://www.w3.org/2001/XMLSchema#string

Cathy Burke

http://www.w3.org/2001/XMLSchema#string

Dana Swartzberg Wollins

http://www.w3.org/2001/XMLSchema#string

Elena M Stoffel

http://www.w3.org/2001/XMLSchema#string

Janette K Merrill

http://www.w3.org/2001/XMLSchema#string

Karen H Lu

http://www.w3.org/2001/XMLSchema#string

Linda Robinson

http://www.w3.org/2001/XMLSchema#string

Marie E Wood

http://www.w3.org/2001/XMLSchema#string

Noralane M Lindor

http://www.w3.org/2001/XMLSchema#string

Sapna Syngal

http://www.w3.org/2001/XMLSchema#string

P2860

A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands

Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma

Juvenile polyposis syndrome

Early malignant progression of hereditary medullary thyroid cancer.

The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history.

Reconsidering the family history in primary care

Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO.

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

AGA technical review on hereditary colorectal cancer and genetic testing.

10 rare tumors that warrant a genetics referral.

P304

833-840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2013.50.9257

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

American Society of Clinical Oncology

Molly S. Daniels

Kevin S. Hughes

P577

2014-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24493721

http://www.w3.org/2001/XMLSchema#string

P932

3940540

http://www.w3.org/2001/XMLSchema#string